Literature DB >> 30746631

Receipt of Preventive Care Services Among US Adults with Inflammatory Bowel Disease, 2015-2016.

Fang Xu1, James M Dahlhamer2, Emily P Terlizzi2, Anne G Wheaton3, Janet B Croft3.   

Abstract

BACKGROUND: Previous reports suggest that adults with inflammatory bowel disease (IBD) receive suboptimal preventive care. AIMS: The population-based study compared the receipt of these services by US adults with and without IBD.
METHODS: Adults aged ≥ 18 years with IBD (1.2%) and without IBD were identified from the 2015 and 2016 National Health Interview Survey (n = 66,610). Age-standardized prevalence of doctor visits, receipt of medical advice, and selected preventive care was calculated for adults with and without IBD. The model-adjusted prevalence ratios were estimated for receipt of preventive care associated with IBD.
RESULTS: The prevalence of a doctor visit in the past 12 months was significantly higher among adults with IBD than those without. IBD was also associated with significantly higher prevalence of receiving medical advice about smoking cessation (83.9% vs. 66.4%) and diet (42.9% vs. 32.1%), having colon cancer screening in the past 12 months (44.0% vs. 26.7%), having ever had an HIV test (51.5% vs. 45.4%) or pneumococcal vaccine (75.3% vs. 64.0%), having received a tetanus vaccine in the past 10 years (72.0% vs. 61.8%), and having received a flu vaccine in the past 12 months (48.4% vs. 41.0%), but was not significantly associated with receiving cervical cancer screening and hepatitis A and B vaccines.
CONCLUSIONS: Adults with IBD were more likely to receive many types of preventive care than adults without IBD. The findings can inform healthcare policy makers to make strategic decisions that enhance multidisciplinary coordination from various medical specialties to ensure optimal preventive care for IBD patients.

Entities:  

Keywords:  Crohn’s disease; Inflammatory bowel disease; Preventive care services; Ulcerative colitis

Mesh:

Year:  2019        PMID: 30746631     DOI: 10.1007/s10620-019-05494-w

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.487


  18 in total

1.  Impact of chronic conditions on quality of life in patients with inflammatory bowel disease.

Authors:  Laura T Pizzi; Christine M Weston; Neil I Goldfarb; Deborah Moretti; Nicole Cobb; Jamie B Howell; Anthony Infantolino; Anthony J Dimarino; Sidney Cohen
Journal:  Inflamm Bowel Dis       Date:  2006-01       Impact factor: 5.325

Review 2.  Intestinal and Extraintestinal Cancers Associated With Inflammatory Bowel Disease.

Authors:  Minna Chang; Liisa Chang; Hanna M Chang; Fuju Chang
Journal:  Clin Colorectal Cancer       Date:  2017-06-27       Impact factor: 4.481

3.  Estimating model-adjusted risks, risk differences, and risk ratios from complex survey data.

Authors:  Gayle S Bieler; G Gordon Brown; Rick L Williams; Donna J Brogan
Journal:  Am J Epidemiol       Date:  2010-02-04       Impact factor: 4.897

Review 4.  Comorbidity in inflammatory bowel disease.

Authors:  Antonio López San Román; Fernando Muñoz
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 5.  Venous thromboembolism in inflammatory bowel disease: an epidemiological review.

Authors:  Sanjay K Murthy; Geoffrey C Nguyen
Journal:  Am J Gastroenterol       Date:  2011-03-15       Impact factor: 10.864

6.  Are primary care providers uncomfortable providing routine preventive care for inflammatory bowel disease patients?

Authors:  Lisbeth Selby; Andrew Hoellein; John F Wilson
Journal:  Dig Dis Sci       Date:  2010-07-29       Impact factor: 3.199

7.  Preventive medical services among patients with rheumatoid arthritis.

Authors:  Hilal Maradit Kremers; Michelle Bidaut-Russell; Christopher G Scott; Megan S Reinalda; Alan R Zinsmeister; Sherine E Gabriel
Journal:  J Rheumatol       Date:  2003-09       Impact factor: 4.666

Review 8.  Cardiovascular involvement in inflammatory bowel disease: Dangerous liaisons.

Authors:  Ana Maria Filimon; Lucian Negreanu; Michelle Doca; Andreea Ciobanu; Carmen Monica Preda; Dragos Vinereanu
Journal:  World J Gastroenterol       Date:  2015-09-07       Impact factor: 5.742

9.  Health-Risk Behaviors and Chronic Conditions Among Adults with Inflammatory Bowel Disease - United States, 2015 and 2016.

Authors:  Fang Xu; James M Dahlhamer; Emily P Zammitti; Anne G Wheaton; Janet B Croft
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-02-16       Impact factor: 17.586

Review 10.  Preventive health measures in inflammatory bowel disease.

Authors:  Ayokunle T Abegunde; Bashir H Muhammad; Tauseef Ali
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

View more
  4 in total

1.  Trends and Outcomes of Hip Fracture Hospitalization Among Medicare Beneficiaries with Inflammatory Bowel Disease, 2000-2017.

Authors:  Fang Xu; Anne G Wheaton; Kamil E Barbour; Yong Liu; Kurt J Greenlund
Journal:  Dig Dis Sci       Date:  2020-07-22       Impact factor: 3.199

2.  Cervical Cancer Screening in Inflammatory Bowel Disease: Who Should Be Screening?

Authors:  Anuj Chhaparia; Florence Odufalu; Mitchell Edwards; Krishna Patel; Kara Christopher; Katie Schroeder; Charlene Prather; Muhammad B Hammami
Journal:  Gastroenterology Res       Date:  2020-10-08

3.  COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.

Authors:  Laura Ramos; Marta Carrillo-Palau; Inmaculada Alonso-Abreu; Cristina Reygosa; Noemi Hernández-Alvarez; Carla Amaral; Anjara Hernández; Federica Benítez-Zafra; Fabiola Pérez-González; Haridian Quintana-Díaz; Manuel Hernandez-Guerra
Journal:  Gastroenterol Hepatol       Date:  2022-05-21       Impact factor: 5.867

Review 4.  Solid extraintestinal malignancies in patients with inflammatory bowel disease.

Authors:  Anastasia Mala; Kalliopi Foteinogiannopoulou; Ioannis E Koutroubakis
Journal:  World J Gastrointest Oncol       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.